Pharmaceutical

The global pharmaceutical industry is undergoing a consolidation phase in order to combat price pressure, competition and patent cliffs. Innovation is of vital importance for steady growth of pharmaceutical companies. Pharmaceutical companies have been mainly dependent on a few blockbuster molecules. However,with rapid decline in research and development (R&D) productivity and non-conducive regulatory environment, companies need to find different avenues of growth. The patent expiry of blockbuster drugs is expected to pave way for generics. Due to difference in genetic composition of varied individuals, innovation is becoming more complex.This is influencing players offering complementary products and services to collaborate for new product development.

There are four major factors that are impacting the value creation in pharmaceutical industry:

  • Market
    • Stress from patent expiries, niche marketing, and patient-centricity is challenging the growth plans of pharmaceutical companies. Moreover, in emerging markets, companies face strong competition from local players,who sell product at a much lower cost. To counter the same global companies need to significantly reduce their profit margins.
  • Technology
    • Rapid integration of healthcare and information technology is posing threat for current blockbuster drugs
    • Products based on new technologies offer superior properties and are more efficient as compared to existing products in the market
  • Regulation
    • There is constant price pressure from governments to meet demands of growing number of patients
    • Emerging markets have regulatory uncertainty, where decisions are made to protect the interests of the general population
    • Moreover, governments, especially in emerging economies are encouraging pharmaceutical companies to focus on preventive measures for diseases, which involves major investments
  • Innovation
    • Need for innovative products or therapies is rising constantly due to rising pressure of patent-cliff coupled with reducing profit margins
    • Identification of new bacterial and viral strains is driving the need for novel drugs

Demand for personalized medicines is increasing in order to ensure effective treatment of various diseases

Investments in R&D for oncology and NCDs are increasing globally in order to provide cost-effective solutions available to ailing patients.

Market Challenges

The industry is facing certain challenges such as patent cliff, cost pressure and regulatory uncertainties across the globe. This is hindering market growth to a certain extent. Moreover, regulatory authorities are becoming more stringent with the drug approval process. However, with respect to drugs for rare diseases, the FDA has offered a fast-track approval process. Moreover, demand for cost-effective treatment for chronic and non-communicable diseases such as diabetes, hypertension, thyroid disorder, obesity, and cancer is increasing. However, there is a dearth of strong products in the pipeline that offer better treatment option with fewer side effects. The fear of side effects and long-term treatment costs is encouraging patients to shift to alternative therapies.

Combating Challenges

Market players need to combat these challenges and keep their pace with the industry to sustain their market share. Mergers, acquisitions, and divestitures of products, companies or business division is a rapidly emerging trend in the market to combat prevalent challenges in the market.Companies are more focused in terms of therapy areas and hence, are divesting less focused therapy businesses. A good example is the swap deal between GSK and Novartis in 2015.

Moreover, pharmaceutical companies are investing in consumer health products,with increasing consumer’s health awareness and emerging trend of self-medication. These trends are encouraging pharmaceutical companies to enter the OTC market and leverage their brand equity among the doctors, chemists and consumers. Companies such as GlaxoSmithKline, Cipla, Pfizer, Merck, Sun Pharma, and Abbott have a focused division or subsidiary for consumer healthcare products and markets.

Moreover, to combat increasing cost pressure, companies are evolving their distribution channel. Establishing facilities or presence through collaboration in regional markets has helped companies meet local demand with reduced costs and delivery time. Emergence of e-pharmacy has resulted in creation of a separate team in the organization to service consumers ordering medicines online. Moreover, companies are connecting with consumers through social media, which helps improve brand visibility. The distribution channel has thus evolved significantly from the decade old channel consisting of only wholesalers and physical retail shops.

Patient-centricity

Patients are increasingly becoming well informed and organized, sometimes demanding for a particular product from prescribers. Therefore, companies need to be more patient-centric in their approach and provide quality care to consumers. Pharmaceutical companies are focusing on established direct to consumer distribution channels and establishing a more strong relationship with them. Moreover, companies are creating a good purchase experience for consumers through different offerings such as post-purchase medical services, engaging the patient through social media and events, and providing regular product alerts and refilling services.

Growth in Emerging Economies

The pharmaceutical industry is rapidly expanding in emerging economies such as Asia Pacific, Africa, and Latin America. These regions possess immense potential for growth of pharmaceutical companies, owing to inadequate access to medicines, growing population and increasing incidence of non-communicable diseases (NCDs). Besides, demand for contract research and manufacturing is also high in these regions. China and India are the largest emerging markets for CRO and CMO. Companies are highly dependent on China for API supply owing to low purchase cost. Overdependence on a single country can pose a challenge for the pharmaceuticals sector in the near future. Therefore, other emerging countries such as India, Brazil and South Africa are encouraging investments in their country. Besides, global companies are establishing their facilities in Asia Pacific, Middle East and Latin America regions to enable close monitoring and servicing of lucrative regional markets.

Conclusion

Pharmaceutical companies need to focus on an integrated, patient-centric, value-driven approach along with technology integration and strategic partnerships in order to capitalize on lucrative growth opportunities in the market. Major global players in the market include Pfizer Inc., Merck & Co., Inc., Bayer AG, GlaxoSmithKline plc., Sanofi, F. Hoffmann-La Roche AG, AstraZeneca plc. and Novartis AG.

There is a paradigm shift in process in the global pharmaceutical industry from product to a ‘Prodice’ (Product and Service) model, to offer affordable, accessible and quality care to patients.

View More

Pharmaceutical Published Insights

Coherent Market Insights Biologics Outsourcing Market

Published Date : May 2023

Global Biologics Outsourcing market is estimated to be valued at US$ 19.67 Billion in 2023 and is expected to exhibit a CAGR of 12.9% during the forecast period (2023-2030). Growing t... View more

Coherent Market Insights Orodispersible Tablets Market

Published Date : Nov 2023

Global orodispersible tablets market experienced a significant expansion in recent years, and is expected to witness growth during the forecast period from 2023 to 2030. Orodispersible tablets, a... View more

Coherent Market Insights Ophthalmic Drugs Market

Published Date : May 2023

The global ophthalmic drugs market was valued at US$ 45.62 Bn in 2022 and is forecast to reach a value of US$ 70.76 Bn by 2030 at a CAGR of 5.64% be... View more

Coherent Market Insights Third Generation Sequencing Market

Published Date : May 2023

The global Third Generation Sequencing market was valued at US$ 8.93 Bn in 2022 and is forecast to reach a value of US$ 23.92 Bn by 2030 at a ... View more

Coherent Market Insights Insulin Lispro Market

Published Date : Oct 2023

Insulin lispro market has been significant due to the increasing prevalence of diabetes globally. The global insulin lispro market size is estimated to be valued at US$ 7.32 Bn in 2023, and is projected to reach US$ 11.15 Bn by 2030 a... View more

Coherent Market Insights Serotonin Norepinephrine Inhibitor Market

Published Date : May 2023

The global serotonin norepinephrine inhibitor market was valued at US$ 6.29 billion in 2022 and is expected to grow at a CAGR of 3.8% from 2023 to 2030. By the end of 2030, the market is projected to reach US$ 8.48 billion... View more

Coherent Market Insights Rabies Antiserum Market

Published Date : Nov 2023

The global rabies antiserum market size was valued at USD 1.24 billion in 2023. The market is projected to grow at a CAGR of 3.3% from 2023 to 2030, resulting in an estimated market size of USD 1.56 billion by the end of 2030... View more

Coherent Market Insights Poultry Antibiotic Market

Published Date : Nov 2023

The global poultry antibiotic market size is estimated to be US$ 2.0 Billion in 2023. The market is expected to experience a moderate growth rate in the coming years, with a projected CAGR of 6% from 2023 to 2030. This would result in... View more

Coherent Market Insights Fish Skin Disease Market

Published Date : Oct 2023

The Global Fish Skin Disease Market, was valued at US$ 1.4 Billion in 2023 and is expected to grow at a compound annual growth rate (CAGR) of 9.8% to reach US$ 2.7 Billion by end of 2030. The growth of the market... View more

Coherent Market Insights Diagnostic Radiopharmaceuticals And Contrast Media Market

Published Date : Apr 2023

The global diagnostic radiopharmaceuticals and contrast media market was valued at US$ 6,434.9 Million in 2022 and is forecast to reach a value of US$ 10,140.7 Mn... View more

Coherent Market Insights Veterinary Medicine Market

Published Date : Apr 2023

The global veterinary medicine market was valued at US$ 32.08 Bn in 2023 and is forecast to reach a value of US$ 50.16 Bn by 2030 at a CAGR of 5.7% between 2... View more

Coherent Market Insights Intramuscular Vaccine Adjuvants Market

Published Date : Apr 2023

The global intramuscular vaccine adjuvants market size was valued at $650.6 million in 2022 and is expected to reach $1,088.9 million by 2030, with a CAGR of 6.7% during the forecast period. The increasing prevalence of infectious diseases, coupled with the growing ne... View more

Coherent Market Insights Biopharma Buffer Market

Published Date : Apr 2023

The global biopharma buffer market size was valued at US$ 3.44 billion in 2022 and is expected to grow at a CAGR of 7.1% to reach US$ 5.95 billion by end of 2030. This growth can be attributed to the increasing demand for biopharmaceuticals and the growing adoption of... View more

Coherent Market Insights Veterinary Dermatology Drugs Market

Published Date : Apr 2023

The global veterinary dermatology drugs market size was valued at US$ 2.43 billion in 2022 and is expected to reach US$ 4.39 billion by end of 2030, growing at a CAGR of 7.67%. The growth of this market is attributed to the rising incidence of skin diseases in animals... View more

Coherent Market Insights Herpes Simplex Virus Treatment Market

Published Date : Apr 2023

The global herpes simplex virus treatment market was valued at US$ 2,246.7 Mn in 2022 and is forecast to reach a value of US$ 3,503.7 Mn by 2030 at a CAGR of... View more

Coherent Market Insights Atrophic Vaginitis Treatment Market

Published Date : Apr 2023

The global atrophic vaginitis market size was valued at USD 612.4 million in 2022 and is expected to grow at a CAGR of 7.5% over the forecast period 2023-2030. Atrophic vaginitis is a condition in which the vaginal walls become thin, dry, and inflamed due to a decreas... View more

Coherent Market Insights Her 2 Negative Breast Cancer Market

Published Date : Mar 2023

The global HER-2 negative breast cancer market was valued at US$ 12,647.0 Mn in 2022 and is forecast to reach a value of US$ 27,201.2 Mn by 2030 at a CAGR of 10.1%&n... View more

Coherent Market Insights Human Platelet Lysate Market

Published Date : Mar 2023

Global human platelet lysate market is estimated to be valued at US$ 53.0 million in 2023 and is expected to exhibit a CAGR of 4.54% during the forecast period (2023-2030). ... View more

Coherent Market Insights Monoclonal Antibody Therapeutics Market

Published Date : Mar 2023

The global monoclonal antibody therapeutics market is estimated to be valued at US$ 205,385.6 million in 2023 and is expected to exhibit a CAGR of 14.6% during the forecast period (2023-2030).... View more

Coherent Market Insights Neuropathic Ocular Pain Market

Published Date : Mar 2023

Global Neuropathic Ocular Pain market is estimated to be valued at US$  197.1 million in 2023 and is expected to exhibit a CAGR of 3.13% during the forecast period (2023... View more

© 2023 Coherent Market Insights Pvt Ltd. All Rights Reserved.